{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T12:36:06Z","timestamp":1791549366642,"version":"4.3.4"},"reference-count":59,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,23]],"date-time":"2026-12-23T00:00:00Z","timestamp":1797984000000},"content-version":"am","delay-in-days":356,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["R00AA030627"],"award-info":[{"award-number":["R00AA030627"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajp.amjpathol.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ajpath.2025.05.013","type":"journal-article","created":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T19:25:24Z","timestamp":1749756324000},"page":"241-255","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Identification of Preclinical Biomarkers of Metabolic Dysfunction\u2013Associated Steatotic Liver Disease versus Metabolic Dysfunction and Alcohol-Associated Liver Disease and the Impact of Diet"],"prefix":"10.1016","volume":"196","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2191-9107","authenticated-orcid":false,"given":"Tyler C.","family":"Gripshover","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui S.","family":"Treves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1955-3046","authenticated-orcid":false,"given":"Josiah E.","family":"Hardesty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpath.2025.05.013_bib1","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/s42255-024-00985-1","article-title":"From NAFLD to MASLD: implications of the new nomenclature for preclinical and clinical research","volume":"6","author":"Hsu","year":"2024","journal-title":"Nat Metab"},{"key":"10.1016\/j.ajpath.2025.05.013_bib2","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.3390\/nu11123067","article-title":"Nonalcoholic fatty liver disease induced by high-fat diet in C57bl\/6 models","volume":"11","author":"Recena Aydos","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.ajpath.2025.05.013_bib3","doi-asserted-by":"crossref","DOI":"10.1172\/JCI176345","article-title":"Alcohol-associated liver disease","volume":"134","author":"Mackowiak","year":"2024","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajpath.2025.05.013_bib4","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s40572-019-00232-w","article-title":"Mechanisms of environmental contributions to fatty liver disease","volume":"6","author":"Wahlang","year":"2019","journal-title":"Curr Environ Health Rep"},{"key":"10.1016\/j.ajpath.2025.05.013_bib5","doi-asserted-by":"crossref","DOI":"10.1177\/17562848231163410","article-title":"Drug-induced liver injury: a comprehensive review","volume":"16","author":"Hosack","year":"2023","journal-title":"Therap Adv Gastroenterol"},{"key":"10.1016\/j.ajpath.2025.05.013_bib6","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s11892-021-01377-5","article-title":"Genetic contribution to non-alcoholic fatty liver disease and prognostic implications","volume":"21","author":"Martin","year":"2021","journal-title":"Curr Diab Rep"},{"key":"10.1016\/j.ajpath.2025.05.013_bib7","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/s41575-023-00800-4","article-title":"Lifestyle interventions in nonalcoholic fatty liver disease","volume":"20","author":"Younossi","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.ajpath.2025.05.013_bib8","series-title":"Front-of-Package Nutrition Rating Systems and Symbols: Phase I Report","article-title":"Institute of Medicine Committee on Examination of Front-of-Package Nutrition Rating S, Symbols","year":"2010"},{"key":"10.1016\/j.ajpath.2025.05.013_bib9","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2025.05.013_bib10","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jhep.2023.03.017","article-title":"Global burden of liver disease: 2023 update","volume":"79","author":"Devarbhavi","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.ajpath.2025.05.013_bib11","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Rinella","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.ajpath.2025.05.013_bib12","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/S0140-6736(18)31310-2","article-title":"Alcohol use and burden for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"392","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.ajpath.2025.05.013_bib13","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/j.1530-0277.2010.01405.x","article-title":"Alcoholic liver disease and malnutrition","volume":"35","author":"McClain","year":"2011","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.ajpath.2025.05.013_bib14","first-page":"296","article-title":"The role of nutritional therapy in alcoholic liver disease","volume":"29","author":"Griffith","year":"2006","journal-title":"Alcohol Res Health"},{"key":"10.1016\/j.ajpath.2025.05.013_bib15","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1093\/alcalc\/agaa121","article-title":"Effect of alcohol combined with high fat diet: two wrongs don't make a right but they could make a good excuse","volume":"56","author":"Dionisi","year":"2021","journal-title":"Alcohol Alcohol"},{"key":"10.1016\/j.ajpath.2025.05.013_bib16","first-page":"219","article-title":"Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man","volume":"50","author":"Freireich","year":"1966","journal-title":"Cancer Chemother Rep"},{"key":"10.1016\/j.ajpath.2025.05.013_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2025.110049","article-title":"Liver-Quant: feature-based image analysis toolkit for automatic quantification of metabolic dysfunction-associated steatotic liver disease","volume":"190","author":"Farzi","year":"2025","journal-title":"Comput Biol Med"},{"key":"10.1016\/j.ajpath.2025.05.013_bib18","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3390\/stats8010018","article-title":"STATom@ic: R package for automated statistical analysis of omic datasets","volume":"8","author":"Treves","year":"2025","journal-title":"Stats"},{"key":"10.1016\/j.ajpath.2025.05.013_bib20","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ajpath.2025.05.013_bib21","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"10.1016\/j.ajpath.2025.05.013_bib22","article-title":"decoupleR: ensemble of computational methods to infer biological activities from omics data","volume":"2","author":"Badia","year":"2022","journal-title":"Bioinform Adv"},{"key":"10.1016\/j.ajpath.2025.05.013_bib23","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.2337\/db23-0858","article-title":"Glucagon resistance in individuals with obesity and hepatic steatosis can be measured using the GLUSENTIC test and index","volume":"73","author":"Kjeldsen","year":"2024","journal-title":"Diabetes"},{"key":"10.1016\/j.ajpath.2025.05.013_bib24","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2337\/db10-0331","article-title":"Mitochondrial biogenesis and peroxisome proliferator-activated receptor-[gamma] coactivator-1[alpha] (PGC-1[alpha]) deacetylation by physical activity: intact adipocytokine signaling is required","volume":"60","author":"Li","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.ajpath.2025.05.013_bib25","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"78","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2025.05.013_bib26","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1111\/acer.14700","article-title":"A Western diet with alcohol in drinking water recapitulates features of alcohol-associated liver disease in mice","volume":"45","author":"Schonfeld","year":"2021","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.ajpath.2025.05.013_bib27","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.3390\/nu14051016","article-title":"High-fat diet augments the effect of alcohol on skeletal muscle mitochondrial dysfunction in mice","volume":"14","author":"Ismaeel","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.ajpath.2025.05.013_bib28","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/ajad.12347","article-title":"Dyslipidemia associated with heavy alcohol use","volume":"25","author":"Capurso","year":"2016","journal-title":"Am J Addict"},{"key":"10.1016\/j.ajpath.2025.05.013_bib29","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1002\/hep4.1698","article-title":"An experimental DUAL model of advanced liver damage","volume":"5","author":"Bened\u00e9-Ubieto","year":"2021","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.ajpath.2025.05.013_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0106159","article-title":"The development of diet-induced obesity and glucose intolerance in C57BL\/6 mice on a high-fat diet consists of distinct phases","volume":"9","author":"Williams","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ajpath.2025.05.013_bib31","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/0026-0495(75)90142-0","article-title":"Effects of ethanol ingestion on glucose tolerance and insulin secretion in normal and diabetic subjects","volume":"24","author":"McMonagle","year":"1975","journal-title":"Metabolism"},{"key":"10.1016\/j.ajpath.2025.05.013_bib32","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/0168-8278(88)80015-1","article-title":"Insulin secretory capacity and the regulation of glucagon secretion in diabetic and non-diabetic alcoholic cirrhotic patients","volume":"28","author":"Kruszynska","year":"1998","journal-title":"J Hepatol"},{"key":"10.1016\/j.ajpath.2025.05.013_bib33","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/s41392-024-01931-z","article-title":"Glucagon-like peptide-1 receptor: mechanisms and advances in therapy","volume":"9","author":"Zheng","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.ajpath.2025.05.013_bib34","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1007\/s12325-021-01710-0","article-title":"Weight loss and maintenance related to the mechanism of action of glucagon-like peptide 1 receptor agonists","volume":"38","author":"Ard","year":"2021","journal-title":"Adv Ther"},{"key":"10.1016\/j.ajpath.2025.05.013_bib35","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1001\/jamapsychiatry.2024.3599","article-title":"Repurposing semaglutide and liraglutide for alcohol use disorder","volume":"82","author":"L\u00e4hteenvuo","year":"2025","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.ajpath.2025.05.013_bib36","doi-asserted-by":"crossref","first-page":"38","DOI":"10.2337\/db23-0356","article-title":"Weight loss-independent effect of liraglutide on insulin sensitivity in individuals with obesity and prediabetes","volume":"73","author":"Mashayekhi","year":"2024","journal-title":"Diabetes"},{"key":"10.1016\/j.ajpath.2025.05.013_bib37","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1475-2840-9-17","article-title":"Elevated circulating levels of an incretin hormone, glucagon-like peptide-1, are associated with metabolic components in high-risk patients with cardiovascular disease","volume":"9","author":"Yamaoka-Tojo","year":"2010","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.ajpath.2025.05.013_bib38","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.jhep.2007.12.017","article-title":"Interleukin-10 is a protective factor against diet-induced insulin resistance in liver","volume":"48","author":"Cintra","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.ajpath.2025.05.013_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.nut.2020.110959","article-title":"Dietary fiber regulates intestinal flora and suppresses liver and systemic inflammation to alleviate liver fibrosis in mice","volume":"81","author":"Li","year":"2021","journal-title":"Nutrition"},{"key":"10.1016\/j.ajpath.2025.05.013_bib40","doi-asserted-by":"crossref","first-page":"619","DOI":"10.4254\/wjh.v11.i8.619","article-title":"Prolonged high-fat-diet feeding promotes non-alcoholic fatty liver disease and alters gut microbiota in mice","volume":"11","author":"Vel\u00e1zquez","year":"2019","journal-title":"World J Hepatol"},{"key":"10.1016\/j.ajpath.2025.05.013_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2022.935612","article-title":"Modulation of gut microbiota and fecal metabolites by corn silk among high-fat diet-induced hypercholesterolemia mice","volume":"9","author":"Ding","year":"2022","journal-title":"Front Nutr"},{"key":"10.1016\/j.ajpath.2025.05.013_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0051907","article-title":"The fecal microbiome in dogs with acute diarrhea and idiopathic inflammatory bowel disease","volume":"7","author":"Suchodolski","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ajpath.2025.05.013_bib43","doi-asserted-by":"crossref","first-page":"3669","DOI":"10.1038\/s41467-023-39403-7","article-title":"Gut microbiota Turicibacter strains differentially modify bile acids and host lipids","volume":"14","author":"Lynch","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.ajpath.2025.05.013_bib44","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.3390\/ijms24032461","article-title":"Microbiome alterations in alcohol use disorder and alcoholic liver disease","volume":"24","author":"Litwinowicz","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ajpath.2025.05.013_bib45","first-page":"515","article-title":"Influence of high-fat diet on gut microbiota: a driving force for chronic disease risk","volume":"18","author":"Murphy","year":"2015","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1016\/j.ajpath.2025.05.013_bib46","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.840164","article-title":"Gut microbiome dysbiosis in alcoholism: consequences for health and recovery","volume":"12","author":"Day","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.ajpath.2025.05.013_bib47","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.jhep.2004.02.029","article-title":"Different expression pattern of hepcidin genes in the liver and pancreas of C57BL\/6N and DBA\/2N mice","volume":"40","author":"Krijt","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.ajpath.2025.05.013_bib48","doi-asserted-by":"crossref","first-page":"523","DOI":"10.3949\/ccjm.89a.21018","article-title":"Cirrhotic coagulopathy: a rebalanced hemostasis","volume":"89","author":"Singh","year":"2022","journal-title":"Cleve Clin J Med"},{"key":"10.1016\/j.ajpath.2025.05.013_bib49","doi-asserted-by":"crossref","DOI":"10.3945\/ajcn.110.001917","article-title":"Regulation of PGC-1[alpha], a nodal regulator of mitochondrial biogenesis","volume":"93","author":"Fernandez-Marcos","year":"2011","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.ajpath.2025.05.013_bib50","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.jhep.2024.06.036","article-title":"Low-to-moderate alcohol consumption is associated with increased fibrosis in individuals with metabolic dysfunction-associated steatotic liver disease","volume":"81","author":"Marti-Aguado","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.ajpath.2025.05.013_bib51","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1152\/physiol.2024.39.S1.1927","article-title":"Low hepatic cardiolipin levels promote increased mitochondrial electron leak and metabolic dysfunction-associated steatohepatitis","volume":"39","author":"Lang","year":"2024","journal-title":"Physiology"},{"key":"10.1016\/j.ajpath.2025.05.013_bib52","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.tem.2010.06.009","article-title":"Retinoid X receptors: common heterodimerization partners with distinct functions","volume":"21","author":"Lefebvre","year":"2010","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.ajpath.2025.05.013_bib53","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.bbalip.2011.09.014","article-title":"The retinoid X receptors and their ligands","volume":"1821","author":"Dawson","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.ajpath.2025.05.013_bib54","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2210434119","article-title":"Phosphorylation of RXR[alpha] mediates the effect of JNK to suppress hepatic FGF21 expression and promote metabolic syndrome","volume":"119","author":"Vernia","year":"2022","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2025.05.013_bib55","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJMoa2309000","article-title":"A phase 3, randomized, controlled trial of resmetirom in NASH with liver fibrosis","volume":"390","author":"Harrison","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpath.2025.05.013_bib56","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.2147\/JIR.S499396","article-title":"Identification of EGR1 as a key diagnostic biomarker in metabolic dysfunction-associated steatotic liver disease (MASLD) through machine learning and immune analysis","volume":"18","author":"Wu","year":"2025","journal-title":"J Inflamm Res"},{"key":"10.1016\/j.ajpath.2025.05.013_bib57","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1161\/01.RES.0000177893.24574.13","article-title":"Interleukin-10 suppresses tissue factor expression in lipopolysaccharide-stimulated macrophages via inhibition of Egr-1 and a serum response element\/MEK-ERK1\/2 pathway","volume":"97","author":"Kamimura","year":"2005","journal-title":"Circ Res"},{"key":"10.1016\/j.ajpath.2025.05.013_bib58","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.immuni.2020.06.003","article-title":"Impaired Kupffer cell self-renewal alters the liver response to lipid overload during non-alcoholic steatohepatitis","volume":"53","author":"Tran","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.ajpath.2025.05.013_bib59","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1016\/j.ajpath.2020.08.014","article-title":"Kupffer cells: inflammation pathways and cell-cell interactions in alcohol-associated liver disease","volume":"190","author":"Slevin","year":"2020","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2025.05.013_bib60","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.jhep.2014.08.010","article-title":"Cirrhosis-associated immune dysfunction: distinctive features and clinical relevance","volume":"61","author":"Albillos","year":"2014","journal-title":"J Hepatol"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944025001956?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944025001956?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T17:16:35Z","timestamp":1768929395000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944025001956"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S0002944025001956"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpath.2025.05.013","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of Preclinical Biomarkers of Metabolic Dysfunction\u2013Associated Steatotic Liver Disease versus Metabolic Dysfunction and Alcohol-Associated Liver Disease and the Impact of Diet","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpath.2025.05.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society for Investigative Pathology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}